REGN fundamentals
An in-depth look to Regeneron Pharmaceuticals, Inc. operating, investing, and financing activities
REGN free cash flow for Q4 23 is 838.3 M USD. For 2023, REGN free cash flow was 3.88 B USD and operating cash flow was 4.59 B USD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM